Weinberg Uri — SEC Form 4 filings
SEC reporting owner CIK 1811030. 7 Form 4 filings on record with FilingPulse; latest filed 2026-03-05.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-02-29 to 2026-03-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 5 filings — 26,687 shares, $411,147 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 7,461 shares @ $13.84 ($103,257) in NovoCure Ltd, filed 2026-03-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NovoCure Ltd (NVCR) | Chf Medical and Innovation Ofr | 7 | — | 8 legs · 26,687 sh · $411,147 | 7 |
Form 4 filings — Weinberg Uri
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-05 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 50,125 @ $0 · Sale (S): 6,412 @ $13.31 · Grant/award (A): 73,340 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | NovoCure Ltd (NVCR) | Sale (S): 7,461 @ $13.84 · Grant/award (A): 12,992 @ $0 · Sale (S): 3,272 @ $13.33 | EDGAR |
| 2025-03-06 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 54,975 @ $18.19 · Grant/award (A): 81,499 (derivative) @ $18.19 | EDGAR |
| 2025-03-04 | 4 | NovoCure Ltd (NVCR) | Sale (S): 268 @ $18.92 | EDGAR |
| 2025-03-03 | 4/A | NovoCure Ltd (NVCR) | Sale (S): 4,326 @ $18.78 · Sale (S): 311 @ $18.31 | EDGAR |
| 2025-03-03 | 4 | NovoCure Ltd (NVCR) | Sale (S): 4,326 @ $18.78 · Sale (S): 311 @ $18.31 | EDGAR |
| 2024-02-29 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 81,799 @ $16.30 · Grant/award (A): 125,078 (derivative) @ $16.30 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1811030 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →